Membrane-Targeted Quantum Dot-Based BACE1 Activity Sensors for In Vitro and In Cellulo Assays

Area of Science:

• Biochemistry
• Neuroscience
• Biotechnology

Background:

• Neurodegenerative diseases like Alzheimer's are increasing with an aging population.
• β-Secretase 1 (BACE1) is a key enzyme in Alzheimer's pathogenesis, producing β-amyloid peptide.
• Existing methods for monitoring BACE1 activity are limited by complexity, stability, and localization challenges.

Purpose of the Study:

• To develop a robust and specific biosensor for measuring BACE1 activity.
• To overcome limitations of existing BACE1 activity assays, particularly regarding acidic pH stability and membrane localization.
• To utilize quantum dots (QDs) for enhanced sensor performance in Alzheimer's disease research.

Main Methods:

• Development of a modular, self-assembling quantum dot (QD) sensor functionalized with peptide substrates and targeting elements.
• Utilizing His-tag self-assembly for precise sensor localization to areas of BACE1 activity.
• Employing high-throughput plate reader assays for in vitro BACE1 activity determination and inhibitor constant calculation.
• Transitioning the sensor to cellular experiments in a neuroblastoma cell line.

Main Results:

• The QD sensor demonstrated stability under acidic conditions, mimicking the cellular environment.
• In vitro assays accurately determined BACE1 activity and yielded the inhibitor constant for verubecestat.
• The sensor successfully detected BACE1 activity and its modulation by inhibitors in a cellular model.

Conclusions:

• The developed QD sensor provides a stable, localized, and sensitive tool for monitoring BACE1 activity.
• This technology facilitates a deeper understanding of BACE1's role in neurodegeneration and aids in evaluating potential therapeutics.
• The sensor represents a significant advancement for Alzheimer's disease research and drug development.